Clinical Trial Update: Efficacy Study of Altabax to Clear Methicillin-resistant Staphylococcus Aureus (MRSA) Nasal Colonization [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Altabax for MRSA nasal colonization was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methicillin-resistant Staphylococcus Aureus
• Methicillin-resistant Staphylococcus Aureus Infection

Drugs mentioned

• Altabax (retapamulin)

Snippet

Sponsor: Ochsner Health System | Conditions: Methicillin-resistant Staphylococcus Aureus | Phase 4 | Status: WITHDRAWN